APREA THERAPEUTICS INC (APRE) Institutional Ownership Changes & 13F Activity
APREA THERAPEUTICS INC (APRE). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Renaissance Technologies LLC, Scientech Research Llc, Citadel Advisors Llc, Diadema Partners Lp, and Geode Capital Management, Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +58,600 | — | 58,600 | $47.02K | Q2 2026 | Sep 02, 2026 |
| Diadema Partners Lp | Buy | +44,907 | — | 44,907 | $36.03K | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Buy | +21,921 | +168.4% | 34,939 | $28.03K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +10,565 | — | 10,565 | $8.48K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +473 | — | 473 | $379.00 | Q2 2026 | Aug 14, 2026 |
| Renaissance Technologies LLC | Buy | +80,700 | +321.5% | 105,800 | $84.88K | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Buy | +13,705 | — | 13,705 | $11.00K | Q2 2026 | Aug 13, 2026 |
| Bnp Paribas Financial Markets | Buy | +5,394 | +13.5% | 45,211 | $36.27K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Buy | +3,500 | +15.7% | 25,830 | $20.72K | Q2 2026 | Aug 13, 2026 |
| Vanguard Capital Management Llc | Buy | +3,260 | +16.6% | 22,882 | $18.35K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Sell | -2,150 | -99.9% | 3 | $2.00 | Q2 2026 | Aug 13, 2026 |
| Fmr Llc | Buy | +45 | — | 45 | $36.00 | Q2 2026 | Aug 13, 2026 |
| Geode Capital Management, Llc | Sell | -44,262 | -37.2% | 74,869 | $60.07K | Q2 2026 | Aug 12, 2026 |
| Tower Research Capital Llc (Trc) | Sell | -1,537 | -30.0% | 3,590 | $2.88K | Q2 2026 | Aug 11, 2026 |
| Persistent Asset Partners Ltd | Buy | +11,490 | — | 11,490 | $9.22K | Q2 2026 | Aug 07, 2026 |
| Lpl Financial Llc | Sell | -5,000 | -23.8% | 16,052 | $12.88K | Q2 2026 | Aug 07, 2026 |
| Blackrock, Inc. | Sell | -1,331 | -15.7% | 7,173 | $5.75K | Q2 2026 | Aug 07, 2026 |
| Scientech Research Llc | Sell | -60,281 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Two Sigma Securities, Llc | Sell | -13,500 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Hightower Advisors, Llc | Sell | -13,864 | -100.0% | 0 | $0.00 | Q2 2026 | May 05, 2026 |
Frequently asked questions about APRE activity
Which institutional owners are buying APRE?
Institutional owners buying APRE include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in APRE activity?
"Buy" means an investor increased their reported position in APRE compared to the prior reporting period. This reflects growing exposure to APREA THERAPEUTICS INC (APRE) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in APRE increasing?
Institutional interest in APRE can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related APRE Institutional Insights
- APRE Overview
- APRE 13F Institutional Holders
- APRE Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- APRE Insider Trading & SEC Form 4 Activity
- APRE Articles
- Top Institutional Investor Stock Rankings